Biao He, Ph.D., is a venture partner at Foothill Ventures (previously named Tsingyuan Ventures), where he has led the firm's biomedical investment since 2017. Before that, Dr. He was a venture partner at TEEC Angel Fund from 2012 to 2017. Dr. He is also a co-founder of ACCB Biotech, Pinpoint Genomics, and Rascal Tx. Dr.

 

He was a Professor in the Department of Surgery and the Cancer Research Center at the University of California, San Francisco (UCSF).  He earned his Ph.D. in Molecular Genetics from the University of Virginia and received a bachelor’s degree and a master’s degree in Biochemistry from Tsinghua University.